Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review

被引:132
|
作者
Chu, Michael J. J. [1 ]
Dare, Anna J. [1 ]
Phillips, Anthony R. J. [1 ,2 ,3 ]
Bartlett, Adam S. J. R. [1 ,2 ,3 ]
机构
[1] Univ Auckland, Dept Surg, Fac Med & Hlth Sci, Auckland 1142, New Zealand
[2] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand
[3] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand
关键词
Fatty liver; Graft survival; Humans; Survival rate; Treatment outcome; PRIMARY NONFUNCTION; PREDICTIVE-VALUE; GRAFT STEATOSIS; MARGINAL DONORS; RISK-FACTORS; CRITERIA; BIOPSIES; PATIENT; IMPACT; MICROSTEATOSIS;
D O I
10.1007/s11605-015-2832-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There is increasing need to expand availability of donor liver grafts, including steatotic livers. Steatotic liver is associated with poor outcome post-transplantation but with conflicting results in the literature. The aim of this systematic review was to evaluate the impact of steatotic livers on liver transplantation outcomes. An electronic search of OVID Medline and Embase databases was performed to identify clinical studies that reported outcomes of steatotic livers in liver transplantation. Data were extracted, and basic descriptive statistics were used to summarise data pooled from individual clinical studies. Ninety-two articles were identified, of which 34 met the inclusion criteria, and stratified analysis were performed. There was a lack of standardised definition of primary non-function or impaired primary function amongst the studies and description of type of steatosis. Severely (> 60 %) steatotic grafts are associated with increased risk of poor graft function, whilst moderate-severe (> 30 %) steatotic grafts are associated with decreased graft survival. Available evidence showed increased risk of poor graft outcome in moderate-severe steatotic livers. A large prospective multi-centred trial will be required to identify the true risks of steatotic livers. Consistent definition of primary non-function/impaired primary function and description of type of steatosis is also required.
引用
收藏
页码:1713 / 1724
页数:12
相关论文
共 50 条
  • [21] THE IMPACT OF HEPATIC STEATOSIS ON THE SELECTION OF POTENTIAL DONORS FOR LIVING DONOR LIVER TRANSPLANTATION
    Lin, Jessica
    Edwards, Diep N.
    Rayapati, Divya
    Woreta, Tinsay A.
    Hamilton, James P.
    Pyda, Jordan S.
    King, Elizabeth
    Wesson, Russell
    Ottmann, Shane E.
    Philosophe, Benjamin
    Gurakar, Ahmet
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1376 - S1376
  • [22] Weight reduction of liver donors with hepatic steatosis as a tool to expand the donor pool for living donor liver transplantation
    Yoon, Y. -I.
    Lee, S. -G.
    Jung, D. H.
    [J]. TRANSPLANTATION, 2022, 106 (8S) : 50 - 50
  • [23] Liver transplantation for hepatic tumors: a systematic review
    Ravaioli, Matteo
    Ercolani, Giorgio
    Neri, Flavia
    Cescon, Matteo
    Stacchini, Giacomo
    Del Gaudio, Massimo
    Cucchetti, Alessandro
    Pinna, Antonio Daniele
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (18) : 5345 - 5352
  • [24] Liver transplantation for hepatic tumors:a systematic review
    Matteo Ravaioli
    Giorgio Ercolani
    Flavia Neri
    Matteo Cescon
    Giacomo Stacchini
    Massimo Del Gaudio
    Alessandro Cucchetti
    Antonio Daniele Pinna
    [J]. World Journal of Gastroenterology, 2014, (18) : 5345 - 5352
  • [25] Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation
    Zamboni, F
    Franchello, A
    David, E
    Rocca, G
    Ricchiuti, A
    Lavezzo, B
    Rizzetto, M
    Salizzoni, M
    [J]. CLINICAL TRANSPLANTATION, 2001, 15 (01) : 53 - 57
  • [26] Clinical outcome of residual liver volume and hepatic steatosis after right lobe living donor hepatectomy.
    Hsieh, C. -E
    Chen, Y. -L
    Lin, K. -H
    Hsu, Y. -L
    Weng, L. -C
    [J]. TRANSPLANTATION, 2019, 103 (08) : 212 - 212
  • [27] Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation
    Cho, Jai Young
    Suh, Kyung-Suk
    Lee, Hae Won
    Cho, Eung-Ho
    Yang, Sung Hoon
    Cho, Yong Beom
    Yi, Nam-Joon
    Kim, Min A.
    Jang, Ja-June
    Lee, Kuhn U. K.
    [J]. TRANSPLANT INTERNATIONAL, 2006, 19 (10) : 807 - 813
  • [28] QUALITY OF LIFE AFTER LIVING DONOR LIVER TRANSPLANTATION: AN UPDATED SYSTEMATIC REVIEW
    Thuluvath, Avesh
    Peipert, John
    Berkowitz, Rachel
    Siddique, Osama
    Mazumder, Nikhilesh
    Levitsky, Josh
    Caicedo-Ramirez, Juan
    Ladner, Daniela P.
    [J]. HEPATOLOGY, 2020, 72 : 837A - 838A
  • [29] Treatment of Rapid Weight Loss in a Donor with Hepatic Steatosis in Living Donor Liver Transplantation: A Case Report
    Yamanaka-Okumura, Hisami
    Urano, Eri
    Kawaura, Akihiko
    Imura, Satoru
    Utsunomiya, Tohru
    Shimada, Mitsuo
    Takeda, Eiji
    [J]. HEPATO-GASTROENTEROLOGY, 2012, 59 (115) : 869 - 871
  • [30] Severe Hepatic Steatosis in Living Donor Liver Transplant Recipients: Clinicopathological Correlation and Outcome
    Jawade, Vaishali Kailash
    Eng, Hock-Liew
    Kuo, Fang-Ying
    Chen, Chao-Long
    Jawade, Kailash K.
    [J]. LIVER TRANSPLANTATION, 2010, 16 (06) : S255 - S256